These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25323165)

  • 21. [Macroangiopathy in 297 type 2 diabetic patients: prevalence and risk factors].
    Bundó Vidiella M; Mundet Tudurí X; Rodríguez Alvarez JL; Trilla Soler M
    Aten Primaria; 1989 May; 6 Spec No():32-6. PubMed ID: 2518999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cerebrovascular risk factors on gray matter volume in adults aged 60-64 years: a voxel-based morphometric study.
    Chen X; Wen W; Anstey KJ; Sachdev PS
    Psychiatry Res; 2006 Oct; 147(2-3):105-14. PubMed ID: 16962291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular risk factors as treatment target to prevent cognitive decline.
    Richard E; Moll van Charante EP; van Gool WA
    J Alzheimers Dis; 2012; 32(3):733-40. PubMed ID: 22886011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults.
    Kuo HK; Chen CY; Liu HM; Yen CJ; Chang KJ; Chang CC; Yu YH; Lin LY; Hwang JJ
    Int J Cardiol; 2010 Aug; 143(2):184-91. PubMed ID: 19261342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent Influences of Cardiovascular Disease Risk Factor Domains on Cognition and Gray and White Matter Morphology.
    Gonzales MM; Ajilore O; Charlton RC; Cohen J; Yang S; Sieg E; Bhaumik DK; Kumar A; Lamar M
    Psychosom Med; 2017 Jun; 79(5):541-548. PubMed ID: 28498826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging small vessel-associated white matter changes in aging.
    Salat DH
    Neuroscience; 2014 Sep; 276():174-86. PubMed ID: 24316059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
    Verdelho A; Madureira S; Ferro JM; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1325-30. PubMed ID: 17470472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerotic arterial wall change of non-stenotic intracracranial arteries on high-resolution MRI at 3.0T: Correlation with cerebrovascular risk factors and white matter hyperintensity.
    Kim TH; Choi JW; Roh HG; Moon WJ; Moon SG; Chun YI; Kim HY
    Clin Neurol Neurosurg; 2014 Nov; 126():1-6. PubMed ID: 25190670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrovascular profile assessment in Parkinson's disease patients.
    Perju-Dumbravă L; Muntean ML; Muresanu DF
    CNS Neurol Disord Drug Targets; 2014; 13(4):712-7. PubMed ID: 24040791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Missing Link in the Pathophysiology of Vascular Cognitive Impairment: Design of the Heart-Brain Study.
    Hooghiemstra AM; Bertens AS; Leeuwis AE; Bron EE; Bots ML; Brunner-La Rocca HP; de Craen AJM; van der Geest RJ; Greving JP; Kappelle LJ; Niessen WJ; van Oostenbrugge RJ; van Osch MJP; de Roos A; van Rossum AC; Biessels GJ; van Buchem MA; Daemen MJAP; van der Flier WM;
    Cerebrovasc Dis Extra; 2017; 7(3):140-152. PubMed ID: 29017156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetes mellitus and aging as a risk factor for cerebral vascular disease: epidemiology, pathophysiology and prevention].
    Cantú-Brito C; Mimenza-Alvarado A; Sánchez-Hernández JJ
    Rev Invest Clin; 2010; 62(4):333-42. PubMed ID: 21222313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of cerebrovascular circulatory disorders].
    Herrschaft H
    Fortschr Neurol Psychiatr; 1985 Sep; 53(9):337-43. PubMed ID: 4043914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of white-matter lesions through control of cerebrovascular risk factors.
    DeCarli C
    Int Psychogeriatr; 2003; 15 Suppl 1():147-51. PubMed ID: 16191232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
    Chiasson JL; Josse RG; Gomis R; Hanefeld M; Karasik A; Laakso M;
    JAMA; 2003 Jul; 290(4):486-94. PubMed ID: 12876091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and physiological MRI correlates of occult cerebrovascular disease in late-onset epilepsy.
    Hanby MF; Al-Bachari S; Makin F; Vidyasagar R; Parkes LM; Emsley HC
    Neuroimage Clin; 2015; 9():128-33. PubMed ID: 26413475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated.
    Brickman AM; Guzman VA; Gonzalez-Castellon M; Razlighi Q; Gu Y; Narkhede A; Janicki S; Ichise M; Stern Y; Manly JJ; Schupf N; Marshall RS
    Neurosci Lett; 2015 Apr; 592():54-8. PubMed ID: 25748319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cerebrovascular disorders as a manifestation of a generalized disease].
    Lechleitner M; Braunsteiner H
    Acta Med Austriaca; 1991; 18(2):47-51. PubMed ID: 1887735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.